Search

Search Constraints

You searched for: Author/Creator Simicek, Michal

Search Results

2. More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia–Like Multiple Myeloma. Issue 7 (1st March 2023)

3. OTUB1 triggers lung cancer development by inhibiting RAS monoubiquitination. Issue 3 (8th February 2016)

4. Single‐agent venetoclax induces MRD‐negative response in relapsed primary plasma cell leukemia with t(11;14). Issue 1 (25th November 2018)

5. Venetoclax plus bortezomib and dexamethasone in heavily pretreated end‐stage myeloma patients without t(11;14): A real‐world cohort. Issue 3 (23rd April 2020)